Lumpectomy Market in the US 2018-2022
A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.
Technavio’s analysts forecast the lumpectomy market in the US to grow at a CAGR of 4.61% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the lumpectomy market in the US for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.Technavio's report, Lumpectomy Market in the US 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Lumpectomy Market in the US 2018-2022
Technavio recognizes the following companies as the key players in the lumpectomy market in the US: Carl Zeiss Meditec, Cianna Medical, DUNE Medical Devices, Endomagnetics, Focal Therapeutics, and iCAD.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is presence of venture capitalists. Most of the companies that are focusing on developing lumpectomy products are US-based companies. They are focused on developing novel technologies and to bring those products into the market for which they need funding for R&D and to conduct clinical trials. Hence, both small and large companies, which manufacture lumpectomy products, need funding sources or investors.”
According to the report, one driver in the market is growing incidence of new breast cancer cases. According to various sources, the number of new breast cancer cases has increased by 4-5 folds in the US from 1980 to 2017. According to various studies, obesity and hormone replacement therapies are the key factors that increased the number of breast cancer cases. According to the NCI in 2014, around 89.7% women survived breast cancer during 2007-2013.
Further, the report states that one challenge in the market is high cost of lumpectomy procedure. The high cost of lumpectomy procedure is negatively affecting the adoption of lumpectomy products. In the below-mentioned table, some of the cost components are mentioned, which can increase the financial burden on patients.
Carl Zeiss Meditec, Cianna Medical, DUNE Medical Devices, Endomagnetics, Focal Therapeutics, and iCAD.